Global Wellness Strategies Inc. announced appointment of Dr. Sud Agarwal as the chief medical advisor to lead the advisory team. His experience and expertise in the psychedelic industry will contribute significantly to efforts in the space moving forward. Dr. Agarwal is a co-founder of Shanti Therapeutics based in Australia, a company focused on pharmaceutical grade psychedelic solutions that Global Wellness recently acquired from Cannvalate Pty Ltd. Shanti is focused on psychedelic MDMA-based drug development and solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | 0.00% | 0.00% | -11.11% |
1st Jan change | Capi. | |
---|---|---|
-11.11% | 1.71M | |
-2.66% | 117B | |
+4.64% | 97.25B | |
+24.39% | 67.56B | |
+9.69% | 65.93B | |
+14.39% | 44.78B | |
+12.43% | 42.92B | |
+6.48% | 25.63B | |
-5.28% | 22.21B | |
-0.27% | 18.37B |
- Stock Market
- Equities
- XTCY Stock
- News Xtacy Therapeutics Corp.
- Global Wellness Strategies Inc. Announces Appointment of Sud Agarwal as the Chief Medical Advisor